Tandon R, DeQuardo J R, Goodson J, Mann N A, Greden J F
Department of Psychiatry, University of Michigan Medical Center, Ann Arbor 48109-0120.
Psychopharmacol Bull. 1992;28(3):297-302.
Anticholinergic drugs have been assumed to have no effects on schizophrenic symptomatology. Some studies suggest, however, that anticholinergic agents may antagonize the beneficial effect of neuroleptics on positive symptoms and partially ameliorate negative symptoms. Virtually all studies have been conducted in patients receiving concomitant neuroleptic treatment, raising the possibility that neuroleptics may obscure or modify any "true" anticholinergic effect on schizophrenic symptoms. To evaluate the hypothesis that anticholinergics may increase positive and decrease negative schizophrenic symptoms, we assessed the effect of biperiden on symptoms in the medication-free state. We studied the effect of biperiden 8 mg/day for 2 days on positive and negative symptoms in 40 otherwise drug-free schizophrenic inpatients. Biperiden produced a significant increase in positive symptoms (t = 6.7, p < .001) and reduction in negative symptoms (t = -3.4, p < .01). These data indicate that cholinergic modulation significantly affects positive and negative schizophrenic symptoms and suggest the need for systematic trials of cholinergic and anticholinergic agents in the treatment of positive and negative symptoms of schizophrenia, respectively.
抗胆碱能药物一直被认为对精神分裂症的症状没有影响。然而,一些研究表明,抗胆碱能药物可能会拮抗抗精神病药物对阳性症状的有益作用,并部分改善阴性症状。几乎所有的研究都是在接受抗精神病药物联合治疗的患者中进行的,这就增加了抗精神病药物可能掩盖或改变抗胆碱能药物对精神分裂症症状的任何“真正”作用的可能性。为了评估抗胆碱能药物可能增加精神分裂症阳性症状并减轻阴性症状这一假设,我们评估了安克痉在未用药状态下对症状的影响。我们研究了40名未服用其他药物的精神分裂症住院患者,给予8毫克/天的安克痉,持续2天,观察其对阳性和阴性症状的影响。安克痉使阳性症状显著增加(t = 6.7,p < .001),阴性症状减少(t = -3.4,p < .01)。这些数据表明,胆碱能调节对精神分裂症的阳性和阴性症状有显著影响,并提示分别需要对胆碱能和抗胆碱能药物治疗精神分裂症阳性和阴性症状进行系统试验。